Our expertise lies in mastering complex products, navigating complicated regulatory pathways, and serving niche patient populations.
Emergency Care: SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. This makes us a trusted partner and one-stop-shop for hospitals, emergency services, health departments, and governments.
Rare Diseases: Our growing rare disease portfolio helps patients with rare neurologic syndromes, metabolic disorders, and rare conditions in oncology. We work to help these patients get the diagnosis they need and access to the treatment options they deserve. This “patient first” culture has helped us to build long-term relationships with the patient groups and key opinion leaders.